While you may have been distracted by Apple’s new product releases and interesting operating system enhancements, the company ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing ...

Researchers have successfully used a quantum algorithm to solve a complex century-old mathematical problem long considered ...

Curis, Inc. ( NASDAQ: CRIS) Cantor Global Healthcare Conference 2025 September 5, 2025 9:45 AM EDT ...

A neuroimaging study conducted in the United Kingdom found that taking the antipsychotic amisulpride (400 mg/day) for one ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Your weekly strategic brief on the cyber threat landscape. Uncover the deeper patterns behind attacks, from bootkit malware ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1Filing based on four Phase 3 studies that met all primary and co-primary endpoints. Th ...

CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LR  Basel, Switzerland.

H.C. Wainwright 27th Annual Global Investment Conference September 10, 2025 10:00 AM EDT Good afternoon. I'm Jim Dentzer, the CEO of Curis. Thank you for taking time today to learn more about us. Over ...

New York City, NY, Sept. 11, 2025 (GLOBE NEWSWIRE) -- An Independent, In-Depth Analysis “Lipomax Drops”?

Coinomize.biz is a bitcoin mixer that acts as a middleman, making your transactions harder to trace. It’s been around since ...